4
Changes in Ownership
RxSight, Inc. Filed Acc 0000950170-24-040174
Chief Financial Officer sold 20,000 shares at an average $49.90 ($997,946)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −8,857 | $49.81 | $441,207 | 19,545 | I |
| Thunen Shelley B Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −800 | $50.27 | $40,218 | 18,745 | I |
| Thunen Shelley B Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −8,938 | $49.81 | $445,225 | 9,807 | I |
| Thunen Shelley B Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −662 | $50.24 | $33,258 | 9,145 | I |
| Thunen Shelley B Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −200 | $50.37 | $10,074 | 8,945 | I |
| Thunen Shelley B Chief Financial Officer | 2024-04-01 | Sale 10b5-1 | −543 | $51.50 | $27,965 | 8,402 | I |
| Open-market sales · 20,000 sh · avg $49.90 · $997,946 | |||||||
Loading xslF345X05/ownership.xml…